| Product Type | Impurity Standards |
| CAT. No. | MRL-C08003 |
| CAS. No. | NA |
| Mol. Formula | C21H20F3IN4O3 |
| Mol. Weight | 560.32 |
| Synonyms | NA |
| Chemical Name | (S)-N-(2,3-Difluoro-6-(3-hydroxy-3-(piperidin-2-yl)azetidine-1-carbonyl)phenyl)-N-(2-fluoro-4-iodophenyl)nitrous amide |
| HSN Code | 38229010 |
| Country of Origin | India |
| Stock Status | Custom Synthesis |
Nitrosamines can be formed through various chemical processes, including the reaction between nitrites and secondary amines in certain conditions. It is a N-Nitroso of secondary amine present in Cobimetinib. Nitrosamines are part of a broader class of compounds known as N-nitroso compounds. Cobimetinib is a kinase inhibitor used in the treatment of certain types of cancer, specifically metastatic melanoma. Structurally, it belongs to the class of MEK inhibitors. Cobimetinib selectively targets MEK1 and MEK2, key components of the MAPK signaling pathway, which is often dysregulated in cancer cells. By inhibiting this pathway, cobimetinib helps suppress the growth and proliferation of cancer cells. Typically administered orally, cobimetinib is often used in combination with other medications, such as a BRAF inhibitor, for a more comprehensive approach in treating metastatic melanoma with specific genetic mutations. Its targeted mechanism makes cobimetinib a valuable addition to the therapeutic options available for certain cancer patients. Buy high quality N-Nitroso Cobimetinib Impurity 1 from Molsyns Research. Molsyns Research is one of the leading manufacturer and exporter of N-Nitroso Cobimetinib Impurity 1